HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
("Jo-Jo Drugstores" or the "Company"), a leading online and offline
retailer and wholesale distributor of pharmaceutical and other
healthcare products and a provider of healthcare services in
China, today announced that the
Company has pledged to provide assistance to those affected by the
contagious virus and fight against the 2019 Novel Coronavirus, or
coronavirus[1] outbreak in Hangzhou, China, where the Company is
headquartered.
To stabilize the medical supply in the market and protect
people's safety in Hangzhou, the
Company has intensified its efforts to help control the spread of
the coronavirus in several perspectives including:
- issuing an initiative (the "Initiative") with other local major
pharmacy chain stores and medical association to the public,
promising and encouraging to run business with honesty and
integrity, and to allocate medical supplies rationally in reaction
to the sell-out of multiple medicines resulting from people's fear
posed by the virus outbreak.
- establishing the "24-hour Coronavirus Emergency Team" and
formulating the "Wuhan Pneumonia Emergency Plan" to ensure the
implementation of the coronavirus prevention and control work.
- entering into emergency work status and contacting over 1,200
domestic and foreign vendors to allocate medical supplies to
stabilize the market and to resist the spread of coronavirus.
- setting up a coronavirus channel on the Company's online
hospital platform to provide medical consultation services and to
provide customers with a 24-hour service hotline.
- popularizing news and information of coronavirus through
various social media platforms to teach people methods to
defend against the virus and to shore up the hope to reduce their
fears of the virus diffusion.
Mr. Lei Liu, Chief Executive Officer and Chairman of Jo-Jo
Drugstores, commented, "We are paying close attention to the
situation and development of the coronavirus. We issued the
Initiative in the first time with Hangzhou Pharmaceutical Industry
Association and nine local influential pharmacy chain companies,
representing an associated business network covering more than
1,000 pharmacies, accounting for about 70% of the total number of
pharmacies in Hangzhou. So far, we
have assembled more than 200,000 protective masks, nearly 10 tons
of disinfection products, and more than 10 varieties of medicines
in short supply, totaling over 300,000 boxes. As a member of the
community and a listed company, it is our duty to make
contributions to the society. We look forward to overcoming the
difficulties and fulfilling our mission of providing quality
medical services to make the people healthier."
[1] 2019 Novel Coronavirus (2019-nCoV)
is a virus (more specifically, a coronavirus) identified as the
cause of an outbreak of respiratory illness first detected in
Wuhan, China. Early on, many of
the patients in the outbreak in Wuhan,
China reportedly had some link to a large seafood and animal
market, suggesting animal-to-person spread. However, a growing
number of patients reportedly have not had exposure to animal
markets, indicating person-to-person spread is occurring. At this
time, it's unclear how easily or sustainably this virus is
spreading between people. The latest situation summary
updates are available on The Centers for Disease Control and
Prevention's web page 2019 Novel Coronavirus, Wuhan, China.
About China Jo-Jo Drugstores,
Inc.
China Jo-Jo Drugstores, Inc.
("Jo-Jo Drugstores" or the "Company"), is a leading online and
offline retailer and wholesale distributor of pharmaceutical and
other healthcare products and a provider of healthcare services
in China. Jo-Jo Drugstores currently operates an online
pharmacy and retail drugstores with licensed doctors on site for
consultation, examination and treatment of common ailments at
scheduled hours. It is also a wholesale distributor of products
similar to those carried in its pharmacies. In addition, Jo-Jo
Drugstores cultivates herbs used for traditional Chinese medicine.
For more information about the Company, please visit
http://jiuzhou360.com. The Company routinely posts important
information on its website.
Forward-Looking Statements
This press release contains information about the Company's
view of its future expectations, plans and prospects that
constitute forward-looking statements. Actual results may
differ materially from historical results or those indicated by
these forward-looking statements as a result of a variety of
factors including, but not limited to, risks and uncertainties
associated with its ability to raise additional funding, its
ability to maintain and grow its business, variability of operating
results, its ability to maintain and enhance its brand, its
development and introduction of new products and services, the
successful integration of acquired companies, technologies and
assets into its portfolio of products and services, marketing and
other business development initiatives, competition in the
industry, general government regulation, economic conditions,
dependence on key personnel, the ability to attract, hire and
retain personnel who possess the technical skills and experience
necessary to meet the requirements of its clients, and its ability
to protect its intellectual property. The Company's encourages
you to review other factors that may affect its future results in
the Company's annual reports and in its other filings with the
Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank
Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Steve Liu
Investor Relations Director
steve.liu@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original
content:http://www.prnewswire.com/news-releases/china-jo-jo-drugstores-steps-in-to-help-combat-the-2019-novel-coronavirus-300997753.html
SOURCE China Jo-Jo Drugstores,
Inc.